FDA Stings Beehive Botanicals For Web Links That "Fell Through The Cracks"
This article was originally published in The Tan Sheet
Executive Summary
Beehive Botanicals has endured product seizure, a complaint from FDA for making unapproved drug claims and potential damage to its reputation because it did not have a complete handle on its Internet presence
You may also be interested in...
Calls For Reporting Requirements, Recall Authority Remain As PCA Crumbles
FDA would have been able to act earlier to limit the impact of contaminated peanut products if food firms were required to report all positive tests for contaminants, according to an agency executive
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands